SAB Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of SAB Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-1.12 | $-1.07 | -4.67 % |
Jun 2024 | 2024-08-08 | $-0.79 | $-1.03 | 23.3 % |
Mar 2024 | 2024-05-20 | $-0.54 | $-0.46 | -17.4 % |
Dec 2023 | 2024-03-29 | $-3.84 | $-0.62 | -519.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $0 | $170.00K | -100.0 % |
Sep 2023 | 2023-11-13 | $1.27M | $20.00K | 6235.0 % |
Mar 2023 | 2023-05-16 | $581.10K | $2.36M | -75.4 % |
Mar 2023 | 2023-04-14 | $2.16M | $6.50M | -66.8 % |
SAB Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
SAB Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-1.12, which missed the estimate of $-1.07.
SAB Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.